Insider Transactions in Q2 2021 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,492
-7.21%
|
$199,332
$21.96 P/Share
|
|
Jun 02
2021
|
Neal Walker INTERIM PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
33,260
-1.32%
|
$698,460
$21.91 P/Share
|
|
Jun 02
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,037
-4.11%
|
$315,777
$21.91 P/Share
|
|
Jun 02
2021
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
21,790
-10.51%
|
$457,590
$21.91 P/Share
|
|
Jun 02
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,119
-4.96%
|
$632,499
$21.91 P/Share
|
|
Jun 02
2021
|
David N. Gordon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
37,914
-10.8%
|
$796,194
$21.88 P/Share
|
|
Jun 01
2021
|
Neal Walker INTERIM PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
73,015
+5.46%
|
-
|
|
Jun 01
2021
|
Frank Ruffo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,189
+15.22%
|
-
|
|
Jun 01
2021
|
Joseph Monahan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+31.82%
|
-
|
|
Jun 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.33%
|
$345,000
$23.15 P/Share
|
|
Jun 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,189
+15.8%
|
-
|
|
Jun 01
2021
|
David N. Gordon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,000
-3.63%
|
$322,000
$23.14 P/Share
|
|
Jun 01
2021
|
David N. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
87,500
+30.87%
|
-
|
|
May 07
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,416
-1.83%
|
$124,568
$23.61 P/Share
|
|
May 07
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,416
+3.51%
|
$54,160
$10.66 P/Share
|
|
May 06
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.81%
|
$345,000
$23.59 P/Share
|
|
May 06
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
May 05
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.74%
|
$360,000
$24.17 P/Share
|
|
May 05
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
May 04
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.77%
|
$360,000
$24.04 P/Share
|
|
May 04
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
May 03
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.83%
|
$360,000
$24.68 P/Share
|
|
May 03
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
Apr 26
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,339
-7.64%
|
$710,814
$26.12 P/Share
|
|
Apr 23
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-7.21%
|
$780,000
$26.99 P/Share
|
|
Apr 22
2021
|
Neal Walker INTERIM PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
30,000
-2.45%
|
$780,000
$26.84 P/Share
|
|
Apr 22
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-12.55%
|
$780,000
$26.84 P/Share
|